These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7859899)

  • 1. [Should we prescribe regular physical activity for patients presenting with type 2 diabetes?].
    Gautier JF
    Diabete Metab; 1994; 20(5):497-500. PubMed ID: 7859899
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating type 2 diabetes--today's targets, tomorrow's goals.
    Alberti KG
    Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S3-10. PubMed ID: 11685827
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes.
    Kadoglou NP; Iliadis F; Liapis CD; Perrea D; Angelopoulou N; Alevizos M
    Diabetes Care; 2007 Sep; 30(9):2242-4. PubMed ID: 17586747
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of exertion on the incidence and course of diabetes mellitus].
    Chełmińska K; Jaremin B; Leo E; Górski J
    Przegl Lek; 1997; 54(1):62-6. PubMed ID: 9190638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physical activity--a crucial factor in the prevention of cardiovascular diseases].
    Anderssen SA; Hjermann I
    Tidsskr Nor Laegeforen; 2000 Oct; 120(26):3168-72. PubMed ID: 11109366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.
    Toledo FG; Menshikova EV; Ritov VB; Azuma K; Radikova Z; DeLany J; Kelley DE
    Diabetes; 2007 Aug; 56(8):2142-7. PubMed ID: 17536063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 12. Exercise and diabetes.
    De Feo P; Di Loreto C; Ranchelli A; Fatone C; Gambelunghe G; Lucidi P; Santeusanio F
    Acta Biomed; 2006; 77 Suppl 1():14-7. PubMed ID: 16921608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and physical activity in the treatment of type 2 diabetes.
    Creviston T; Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):243-71, vi. PubMed ID: 11382562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.
    Wagner H; Degerblad M; Thorell A; Nygren J; Ståhle A; Kuhl J; Brismar TB; Ohrvik J; Efendic S; Båvenholm PN
    Diabetes Care; 2006 Jul; 29(7):1471-7. PubMed ID: 16801564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME
    J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.